alpha-aminopyridine has been researched along with Cardiac Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Fu, J; Fu, Q; Hu, Y; Huang, K; Tao, X; Xu, R; Yang, X | 1 |
| Jaillon, P | 1 |
| Daly, K; Jewitt, DE; Timmis, A | 1 |
4 other study(ies) available for alpha-aminopyridine and Cardiac Diseases
| Article | Year |
|---|---|
Roflumilast-Mediated Phosphodiesterase 4D Inhibition Reverses Diabetes-Associated Cardiac Dysfunction and Remodeling: Effects Beyond Glucose Lowering.
Topics: Aminopyridines; Animals; Benzamides; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclopropanes; Diabetes Mellitus, Type 2; Glucose; Heart Diseases; Humans; Hyperglycemia; Insulins; Mice; MicroRNAs; Phosphodiesterase 4 Inhibitors | 2022 |
[New cardiotonic agents].
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Heart Diseases; Humans; Phosphodiesterase Inhibitors | 1983 |
Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Contrast Media; Heart Diseases; Hemodynamics; Humans | 1983 |
A symposium: Amrinone. November 11, 1984, Miami, Florida.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Heart Diseases; Humans | 1985 |